Published in Women's Health Law Weekly, January 2nd, 2005
L.F. Santana and colleagues, University of Sao Paulo, Brazil, conducted "a longitudinal prospective study ... in 21 women with polycystic ovary syndrome (PCOS), aged 27.20 ± 5.02 years and treated with metformin (1500 mg/day) for 8 weeks."
"The patients were assessed for spontaneous menstruation, weight, body mass index (BMI), waist circumference, waist/hip ratio (WHR), glucose and insulin concentrations under fasting conditions and after a 75-g glucose tolerance test, lipid profile, testosterone, androstenedione, dehydroepiandrosterone sulfate,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly